95 related articles for article (PubMed ID: 21775151)
1. Bivalent ligand approach on N-{2-[(3-methoxyphenyl)methylamino]ethyl}acetamide: synthesis, binding affinity and intrinsic activity for MT(1) and MT(2) melatonin receptors.
Spadoni G; Bedini A; Orlando P; Lucarini S; Tarzia G; Mor M; Rivara S; Lucini V; Pannacci M; Scaglione F
Bioorg Med Chem; 2011 Aug; 19(16):4910-6. PubMed ID: 21775151
[TBL] [Abstract][Full Text] [Related]
2. 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.
Zlotos DP; Attia MI; Julius J; Sethi S; Witt-Enderby PA
J Med Chem; 2009 Feb; 52(3):826-33. PubMed ID: 19193160
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
[TBL] [Abstract][Full Text] [Related]
4. N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands.
Rivara S; Vacondio F; Fioni A; Silva C; Carmi C; Mor M; Lucini V; Pannacci M; Caronno A; Scaglione F; Gobbi G; Spadoni G; Bedini A; Orlando P; Lucarini S; Tarzia G
ChemMedChem; 2009 Oct; 4(10):1746-55. PubMed ID: 19728346
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of 2-phenylimidazo[1,2-a]pyridines as a novel class of melatonin receptor ligands.
El Kazzouli S; Griffon du Bellay A; Berteina-Raboin S; Delagrange P; Caignard DH; Guillaumet G
Eur J Med Chem; 2011 Sep; 46(9):4252-7. PubMed ID: 21764185
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.
Leclerc V; Ettaoussi M; Rami M; Farce A; Boutin JA; Delagrange P; Caignard DH; Renard P; Berthelot P; Yous S
Eur J Med Chem; 2011 May; 46(5):1622-9. PubMed ID: 21377769
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and melatoninergic potency of new N-acyl 8,9-dihydro-4-methoxy-7H-2-benzo[de]quinolinalkanamines.
Tsotinis A; Eleutheriades A; Hough KA; Davidson K; Sugden D
Bioorg Chem; 2007 Apr; 35(2):189-204. PubMed ID: 17223160
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.
Mésangeau C; Pérès B; Descamps-François C; Chavatte P; Audinot V; Coumailleau S; Boutin JA; Delagrange P; Bennejean C; Renard P; Caignard DH; Berthelot P; Yous S
Bioorg Med Chem; 2010 May; 18(10):3426-36. PubMed ID: 20444610
[TBL] [Abstract][Full Text] [Related]
10. N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.
Rivara S; Lodola A; Mor M; Bedini A; Spadoni G; Lucini V; Pannacci M; Fraschini F; Scaglione F; Sanchez RO; Gobbi G; Tarzia G
J Med Chem; 2007 Dec; 50(26):6618-26. PubMed ID: 18052314
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.
Rivara S; Mor M; Silva C; Zuliani V; Vacondio F; Spadoni G; Bedini A; Tarzia G; Lucini V; Pannacci M; Fraschini F; Plazzi PV
J Med Chem; 2003 Apr; 46(8):1429-39. PubMed ID: 12672242
[TBL] [Abstract][Full Text] [Related]
12. N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.
Markl C; Clafshenkel WP; Attia MI; Sethi S; Witt-Enderby PA; Zlotos DP
Arch Pharm (Weinheim); 2011 Oct; 344(10):666-74. PubMed ID: 21887801
[TBL] [Abstract][Full Text] [Related]
13. Bivalent ligand approach on 4-[2-(3-methoxyphenyl)ethyl]-1-(2-methoxyphenyl)piperazine: synthesis and binding affinities for 5-HT(7) and 5-HT(1A) receptors.
Leopoldo M; Lacivita E; Colabufo NA; Niso M; Berardi F; Perrone R
Bioorg Med Chem; 2007 Aug; 15(15):5316-21. PubMed ID: 17517509
[TBL] [Abstract][Full Text] [Related]
14. Tricyclic alkylamides as melatonin receptor ligands with antagonist or inverse agonist activity.
Lucini V; Pannacci M; Scaglione F; Fraschini F; Rivara S; Mor M; Bordi F; Plazzi PV; Spadoni G; Bedini A; Piersanti G; Diamantini G; Tarzia G
J Med Chem; 2004 Aug; 47(17):4202-12. PubMed ID: 15293992
[TBL] [Abstract][Full Text] [Related]
15. Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.
Tsotinis A; Vlachou M; Papahatjis DP; Calogeropoulou T; Nikas SP; Garratt PJ; Piccio V; Vonhoff S; Davidson K; Teh MT; Sugden D
J Med Chem; 2006 Jun; 49(12):3509-19. PubMed ID: 16759094
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of substituted N-[3-(3-methoxyphenyl)propyl] amides as highly potent MT(2)-selective melatonin ligands.
Hu Y; Ho MK; Chan KH; New DC; Wong YH
Bioorg Med Chem Lett; 2010 Apr; 20(8):2582-5. PubMed ID: 20227878
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of new melatonin dimeric derivatives.
Di Giacomo B; Bedini A; Spadoni G; Tarzia G; Fraschini F; Pannacci M; Lucini V
Bioorg Med Chem; 2007 Jul; 15(13):4643-50. PubMed ID: 17481904
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 3-phenyltetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Part II.
Durieux S; Chanu A; Bochu C; Audinot V; Coumailleau S; Boutin JA; Delagrange P; Caignard DH; Bennejean C; Renard P; Lesieur D; Berthelot P; Yous S
Bioorg Med Chem; 2009 Apr; 17(8):2963-74. PubMed ID: 19329323
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.
Carocci A; Catalano A; Lovece A; Lentini G; Duranti A; Lucini V; Pannacci M; Scaglione F; Franchini C
Bioorg Med Chem; 2010 Sep; 18(17):6496-511. PubMed ID: 20674373
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
Poissonnier-Durieux S; Ettaoussi M; Pérès B; Boutin JA; Audinot V; Bennejean C; Delagrange P; Caignard DH; Renard P; Berthelot P; Lesieur D; Yous S
Bioorg Med Chem; 2008 Sep; 16(18):8339-48. PubMed ID: 18778943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
